Holen Sie sich die Stockscreener-App
5.29
4.13%
0.21
Handel nachbörslich:
5.61
0.32
+6.05%
Schlusskurs vom Vortag:
$5.08
Offen:
$5.1
24-Stunden-Volumen:
544.91K
Relative Volume:
2.66
Marktkapitalisierung:
$288.71M
Einnahmen:
$21.05M
Nettoeinkommen (Verlust:
$-89.22M
KGV:
-1.8304
EPS:
-2.89
Netto-Cashflow:
$-64.50M
1W Leistung:
+11.37%
1M Leistung:
-3.99%
6M Leistung:
-38.20%
1J Leistung:
+29.66%
1-Tages-Spanne:
$5.065
$5.98
1-Wochen-Bereich:
$4.53
$5.98
52-Wochen-Spanne:
$3.73
$9.69
Tscan Therapeutics Inc Stock (TCRX) Company Profile
Firmenname
Tscan Therapeutics Inc
Sektor
Branche
Telefon
857-399-9500
Adresse
880 WINTER STREET, WALTHAM
Tscan Therapeutics Inc Stock (TCRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-16 | Eingeleitet | BTIG Research | Buy |
| 2024-05-13 | Eingeleitet | Needham | Buy |
| 2023-06-22 | Eingeleitet | Wedbush | Outperform |
Tscan Therapeutics Inc Aktie (TCRX) Neueste Nachrichten
TScan Therapeutics Announces Upcoming Oral Presentation of - GlobeNewswire
TScan Therapeutics Announces Upcoming Oral Presentation of Data from the ALLOHA™ Phase 1 Heme Trial at the 66th American Society of Hematology Annual Meeting and Exposition - StockTitan
TScan Therapeutics' SWOT analysis: innovative therapy stock faces pivotal year - Investing.com India
Waltham cancer biotech adds to real estate footprint - The Business Journals
TScan Therapeutics (NASDAQ:TCRX) Enters Second Amendment for Lease Agreement to Expand Operations at Winter Street FacilityOn October 28, 2024, TScan Therapeutics, Inc. finalized a second amendment to its lease agreement with PPF OFF 828-83 - Defense World
Head to Head Review: ProKidney (NASDAQ:PROK) vs. TScan Therapeutics (NASDAQ:TCRX) - Defense World
The Manufacturers Life Insurance Company Invests $90,000 in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World
Where are the Opportunities in (TCRX) - Stock Traders Daily
BTIG Initiates Coverage of TScan Therapeutics (TCRX) with Buy Recommendation - MSN
Bank of Montreal Can Acquires Shares of 120,454 TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat
Bank of Montreal Can Invests $749,000 in TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat
TScan Therapeutics, Inc. (NASDAQ:TCRX) Stock Position Lifted by Marshall Wace LLP - MarketBeat
American Century Companies Inc. Increases Position in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World
TCRXTScan Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
TScan Therapeutics Announces Upcoming Presentations at the - GlobeNewswire
TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual Meeting - StockTitan
Reviewing TScan Therapeutics (NASDAQ:TCRX) and Sorrento Therapeutics (OTCMKTS:SRNEQ) - Defense World
Tscan Therapeutics Inc [TCRX] Stock bought by Insider Klencke Barbara for $26450.0 - Knox Daily
Was there any good news for Tscan Therapeutics Inc (TCRX) stock in the last session? - US Post News
Market Momentum Report: Tscan Therapeutics Inc (TCRX)’s Negative Close at 4.98 - The Dwinnex
TScan Therapeutics's SWOT analysis: biotech stock faces pivotal year - Investing.com
TScan Therapeutics, Inc. (NASDAQ:TCRX) Sees Significant Growth in Short Interest - MarketBeat
92,832 Shares in TScan Therapeutics, Inc. (NASDAQ:TCRX) Bought by Troluce Capital Advisors LLC - Defense World
TScan Therapeutics, Inc. (NASDAQ:TCRX) Director Barbara Klencke Acquires 5,000 Shares - Defense World
TScan therapeutics director buys $26,450 in company stock By Investing.com - Investing.com South Africa
TScan therapeutics director buys $26,450 in company stock - Investing.com
940,831 Shares in TScan Therapeutics, Inc. (NASDAQ:TCRX) Purchased by Great Point Partners LLC - Defense World
Great Point Partners LLC Makes New Investment in TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat
Bank of New York Mellon Corp Purchases New Shares in TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat
TScan Therapeutics, Inc. (NASDAQ:TCRX) Shares Sold by Marathon Trading Investment Management LLC - Defense World
When the Price of (TCRX) Talks, People Listen - Stock Traders Daily
TCRX Stock Sees Surge of Approximately 1.08% in Last Five Days - Knox Daily
Can Tscan Therapeutics Inc Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle
Its Stock Has Paid Off Big Time For Tscan Therapeutics Inc - SETE News
TScan Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire
TScan Therapeutics Director Acquires 18% More Stock - Simply Wall St
How To Trade (TCRX) - Stock Traders Daily
TScan Therapeutics, Inc. (NASDAQ:TCRX) Insider Zoran Zdraveski Sells 164,686 Shares of Stock - Defense World
TScan Therapeutics, Inc. (NASDAQ:TCRX) Director Acquires $27,650.00 in Stock - MarketBeat
TScan Therapeutics director buys $56,100 in company shares - Investing.com India
TScan therapeutics executive sells over $950k in company stock By Investing.com - Investing.com Canada
TScan Therapeutics: Speculative Buy With Near-Term Catalysts In Oncology (TCRX) - Seeking Alpha
TScan Therapeutics, Inc. (NASDAQ:TCRX) to Post FY2024 Earnings of ($1.07) Per Share, Lifesci Capital Forecasts - MarketBeat
FY2024 Earnings Estimate for TScan Therapeutics, Inc. Issued By Lifesci Capital (NASDAQ:TCRX) - Defense World
FY2024 EPS Estimates for TScan Therapeutics, Inc. Decreased by Analyst (NASDAQ:TCRX) - Defense World
TScan Therapeutics, Inc. Forecasted to Earn Q3 2024 Earnings of ($0.31) Per Share (NASDAQ:TCRX) - Defense World
TScan Therapeutics (NASDAQ:TCRX) Issues Quarterly Earnings Results - MarketBeat
TScan Therapeutics (NASDAQ:TCRX) Receives Buy Rating from HC Wainwright - Defense World
TScan Therapeutics (NASDAQ:TCRX) Rating Reiterated by Needham & Company LLC - Defense World
TScan Therapeutics (NASDAQ:TCRX) Receives “Outperform” Rating from Wedbush - Defense World
Expert Outlook: TScan Therapeutics Through The Eyes Of 5 Analysts - Benzinga
Finanzdaten der Tscan Therapeutics Inc-Aktie (TCRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tscan Therapeutics Inc-Aktie (TCRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Klencke Barbara | Director |
Aug 23 '24 |
Buy |
5.69 |
5,000 |
28,450 |
35,000 |
| Klencke Barbara | Director |
Aug 26 '24 |
Buy |
5.53 |
5,000 |
27,650 |
40,000 |
| ZDRAVESKI ZORAN | See Remarks |
Aug 23 '24 |
Option Exercise |
3.38 |
157,186 |
531,520 |
169,402 |
| ZDRAVESKI ZORAN | See Remarks |
Aug 23 '24 |
Sale |
5.78 |
164,686 |
952,116 |
4,716 |
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):